Literature DB >> 31154061

A human-derived prostate co-culture microtissue model using epithelial (RWPE-1) and stromal (WPMY-1) cell lines.

Matthew P Dent1, Samantha J Madnick2, Susan Hall2, Marguerite Vantangoli Policelli2, Chloe Bars2, Hui Li2, Ali Amin3, Paul L Carmichael4, Francis L Martin5, Kim Boekelheide2.   

Abstract

The development and normal function of prostate tissue depends on signalling interactions between stromal and epithelial compartments. Development of a prostate microtissue composed of these two components can help identify substance exposures that could cause adverse effects in humans as part of a non-animal risk assessment. In this study, prostate microtissues composed of human derived stromal (WPMY-1) and epithelial (RWPE-1) cell lines grown in scaffold-free hydrogels were developed and characterized using immunohistochemistry, light microscopy, and qRT-PCR. Within 5 days after seeding, the microtissues self-organized into spheroids consisting of a core of stromal WPMY-1 cells surrounded by epithelial RWPE-1 cells. The RWPE-1 layer is reflective of intermediate prostatic epithelium, expressing both characteristics of the luminal (high expression of PSA) and basal (high expression of cytokeratins 5/6 and 14) epithelial cells. The response of the microtissues to an androgen (dihydrotestosterone, DHT) and an anti-androgen (flutamide) was also investigated. Treatment with DHT, flutamide or a mixture of DHT and flutamide indicated that the morphology and self-organization of the microtissues is androgen dependent. qRT-PCR data showed that a saturating concentration of DHT increased the expression of genes coding for the estrogen receptors (ESR1 and ESR2) and decreased the expression of CYP1B1 without affecting the expression of the androgen receptor. With further development and optimization RWPE-1/WPMY-1 microtissues can play an important role in non-animal risk assessments.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31154061      PMCID: PMC6717042          DOI: 10.1016/j.tiv.2019.05.023

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  23 in total

1.  Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate.

Authors:  E R Sherwood; G Theyer; G Steiner; L A Berg; J M Kozlowski; C Lee
Journal:  Prostate       Date:  1991       Impact factor: 4.104

Review 2.  Hedgehog signaling in prostate epithelial-mesenchymal growth regulation.

Authors:  Yu-Ching Peng; Alexandra L Joyner
Journal:  Dev Biol       Date:  2015-01-29       Impact factor: 3.582

3.  Identification of intermediate cell types by keratin expression in the developing human prostate.

Authors:  Y Xue; F Smedts; F M Debruyne; J J de la Rosette; J A Schalken
Journal:  Prostate       Date:  1998-03-01       Impact factor: 4.104

Review 4.  Stromal-epithelial interactions in the normal and neoplastic prostate.

Authors:  S W Hayward; M A Rosen; G R Cunha
Journal:  Br J Urol       Date:  1997-04

5.  Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.

Authors:  Mark A Titus; Michael J Schell; Fred B Lih; Kenneth B Tomer; James L Mohler
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

6.  Stromal-epithelial interactions and heterogeneity of proliferative activity within the prostate.

Authors:  G R Cunha; A A Donjacour; Y Sugimura
Journal:  Biochem Cell Biol       Date:  1986-06       Impact factor: 3.626

Review 7.  Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.

Authors:  Helmut Bonkhoff
Journal:  Prostate       Date:  2017-11-02       Impact factor: 4.104

Review 8.  Testosterone effects on the breast: implications for testosterone therapy for women.

Authors:  Woraluk Somboonporn; Susan R Davis
Journal:  Endocr Rev       Date:  2004-06       Impact factor: 19.871

9.  Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone.

Authors:  J P Michiel Sedelaar; John T Isaacs
Journal:  Prostate       Date:  2009-12-01       Impact factor: 4.104

10.  Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.

Authors:  Inik Chang; Yozo Mitsui; Seul Ki Kim; Ji Su Sun; Hye Sook Jeon; Jung Yun Kang; Nam Ju Kang; Shinichiro Fukuhara; Ankurpreet Gill; Varahram Shahryari; Z Laura Tabatabai; Kirsten L Greene; Rajvir Dahiya; Dong Min Shin; Yuichiro Tanaka
Journal:  Oncotarget       Date:  2017-06-13
View more
  1 in total

1.  Protective Role of 4-(4-Hydroxy-3-methoxyphenyl)-2-Butanone on Prostatic Cells Hyperplasia of Rats and Human, 5α-reductase Inhibition Pathway.

Authors:  Ahmed S Ahmed; Mohamed Gaber Soliman
Journal:  J Microsc Ultrastruct       Date:  2021-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.